Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae
Open Access
- 1 November 2002
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 61 (11) , 981-985
- https://doi.org/10.1136/ard.61.11.981
Abstract
Background: Chondromalacia patellae is a potentially disabling disorder characterised by features of patellar cartilage degradation. Objective: To evaluate markers of cartilage and bone turnover in patients with chondromalacia patellae. Methods: 18 patients with chondromalacia patellae were studied. Serum cartilage oligomeric matrix protein (s-COMP) and bone sialoprotein (s-BSP) levels were measured by enzyme linked immunosorbent assay (ELISA) and compared with those of age and sex matched healthy control subjects. Periarticular bone mineral density (BMD) of both knee joints was assessed by dual energy x ray absorptiometry (DXA). Results: s-COMP levels were significantly raised in all patients with chondromalacia patellae compared with healthy control subjects (p=0.0001). s-BSP levels did not differ significantly between the groups (p=0.41). BMD of the patella was significantly reduced in patients with chondromalacia patellae compared with the control subjects (p=0.016). In patients with bilateral chondromalacia patellae, BMD of the patella was lower in the more symptomatic knee joint (p=0.005). Changes in periarticular BMD were localised to the patella and were not present in femoral regions. Neither s-COMP (p=0.18) nor s-BSP (p=0.40) levels correlated with patellar BMD. Conclusions: Increased s-COMP levels, reflecting cartilage degradation, and reduced BMD localised to the patella may represent clinically useful markers in the diagnosis and monitoring of patients with chondromalacia patellae. Measures of cartilage degradation did not correlate with loss of patellar bone density, suggesting dissociated pathophysiological mechanisms.Keywords
This publication has 31 references indexed in Scilit:
- IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.1999
- Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patellaOsteoarthritis and Cartilage, 1998
- Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint.Rheumatology, 1998
- The distribution of Cartilage Oligomeric Matrix Protein (COMP) in tendon and its variation with tendon site, age and loadMatrix Biology, 1997
- RELATIONSHIP BETWEEN SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN LEVELS AND DISEASE PROGRESSION IN OSTEOARTHRITIS OF THE KNEE JOINTRheumatology, 1995
- Cartilage oligomeric matrix protein (COMP) is an abundant component of tendonFEBS Letters, 1994
- Detection and staging of chondromalacia patellae: relative efficacies of conventional MR imaging, MR arthrography, and CT arthrography.American Journal of Roentgenology, 1994
- Bone mineral loss after lower extremity trauma: 62 cases followed for 15–38 yearsActa Orthopaedica, 1993
- Comparison and investigation of bone mineral density in opposing femora by dual-energy X-ray absorptiometryOsteoporosis International, 1992
- Isolation and characterization of two sialoproteins present only in bone calcified matrixBiochemical Journal, 1985